Gyros appoints Dr. Jack Johansen and Mr. Lars Eric Utterman as Non-executives Directors to the Board of Directors

08-Jul-2009 - Sweden

Gyros AB has appointed Dr. Jack Johansen and Mr. Lars Eric Utterman as Non-executives Directors to its Board of Directors. These appointments bring significant executive and board level experience for the development and commercialization of novel technologies used in biopharmaceutical discovery and development. The appointments follow the recent completion of a successful equity fundraising that saw the Company raise SEK 80 million (approximately €7.43m) from its existing investors to drive the further commercialization of its Gyrolab® technology.

Jack Johansen is as an executive consultant to various life science/venture capital companies, including Novo A/S. From 1995-2001, he was a founding CEO of two life science diagnostic companies, Boston Biosystems, Inc. and Boston Probes, Inc., both of which were sold. Prior to this, he was Executive Vice President of science and technology at Millipore Corporation and President of Millicorp, which is Millipore’s venture fund. Dr. Johansen is Chairman of the Board of Directors of Protein Forest, Inc. and AdvanDx Inc. and serves on the Board of Directors of Symphogen A/S and 7TM A/S.

Lars Eric Utterman is Chairman of the board of Ludesi AB and Cellectricon AB and board member of LIVC Technologies GmbH. As an executive consultant, he was engaged by Gyros during 2008 and now serves as interim manager of IonGate Biosciences GmbH. He has held a number of executive positions at international level for more than 30 years with GE Healthcare, Amersham, Pharmacia and Boehringer Mannheim (now Roche Diagnostics).

https://www.bionity.com/en/news/103020/gyros-appoints-dr-jack-johansen-and-mr-lars-eric-utterman-as-non-executives-directors-to-the-board-of-directors.html